Acelyrin Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023
Market Capitalization	475	726
Enterprise Value	-245	6
PE Ratio	-1.90	-1.90
PB Ratio	0.72	1.11
P/FCF Ratio	-4.22	-4.22
P/OCF Ratio	-4.28	-4.28
EV/EBITDA Ratio	-0.02	-0.02
EV/EBIT Ratio	-0.02	-0.02
EV/FCF Ratio	-0.04	-0.04
Debt / Equity Ratio	0.00	0.00
Debt / EBITDA Ratio	0.00	0.00
Debt / FCF Ratio	-0.01	-0.01
Quick Ratio	8.47	8.47
Current Ratio	8.65	8.65
Return on Equity (ROE)	-74.60%	-74.60%
Return on Assets (ROA)	-57.00%	-57.00%
Return on Capital (ROIC)	-64.19%	-64.19%
Earnings Yield	-80.34%	-52.56%
FCF Yield	-36.21%	-23.69%
Buyback Yield / Dilution	-4410.31%	-4410.31%
Total Shareholder Return	-4410.31%	-4410.31%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).